Literature DB >> 15913547

Unique complex between bacterial azurin and tumor-suppressor protein p53.

David Apiyo1, Pernilla Wittung-Stafshede.   

Abstract

The tumor-suppressor protein p53 is a major player in regulation of cell growth, genomic stability, and cell death. Recent work suggests that Pseudomonas aeruginosa azurin, as the only bacterial protein known to date, can enter cancer cells and interact with p53 promoting cell death. For the first time, here we demonstrate and characterize this proposed complex using purified proteins in vitro. We find that azurin binds to p53 with nanomolar affinity in a four-to-one stoichiometry (pH 7.5, 25 degrees C). Upon azurin binding, secondary structure is induced and tryptophan fluorescence is quenched, implying that interactions occur in the N-terminal p53 domain which is also the binding site for many oncogenes. Further biophysical studies may assist the design of novel cancer treatments that are based on azurin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15913547     DOI: 10.1016/j.bbrc.2005.05.038

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells.

Authors:  Nafiseh Paydarnia; Shahryar Khoshtinat Nikkhoi; Azita Fakhravar; Mohsen Mehdiabdol; Hedieh Heydarzadeh; Saeed Ranjbar
Journal:  Mol Biol Rep       Date:  2019-04-01       Impact factor: 2.316

2.  Translocation of a thioether-bridged azurin peptide fragment via the sec pathway in Lactococcus lactis.

Authors:  Anneke Kuipers; Rick Rink; Gert N Moll
Journal:  Appl Environ Microbiol       Date:  2009-03-27       Impact factor: 4.792

Review 3.  Potent and tumor specific: arming bacteria with therapeutic proteins.

Authors:  Nele Van Dessel; Charles A Swofford; Neil S Forbes
Journal:  Ther Deliv       Date:  2015-03

Review 4.  Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.

Authors:  Meng Gao; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  Protein Sci       Date:  2017-10-27       Impact factor: 6.725

Review 5.  Microbial-based therapy of cancer: current progress and future prospects.

Authors:  Nuno Bernardes; Raquel Seruca; Ananda M Chakrabarty; Arsenio M Fialho
Journal:  Bioeng Bugs       Date:  2009-12-02

6.  A novel and rapid LC/MS/MS assay for bioanalysis of Azurin p28 in serum and its pharmacokinetics in mice.

Authors:  Greg S Gorman; Lori U Coward; Lea Freeman; Pat E Noker; Craig W Beattie; Lee Jia
Journal:  J Pharm Biomed Anal       Date:  2010-06-30       Impact factor: 3.935

7.  Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.

Authors:  Anna Rita Bizzarri; Simona Santini; Emilia Coppari; Monica Bucciantini; Silvia Di Agostino; Tohru Yamada; Craig W Beattie; Salvatore Cannistraro
Journal:  Int J Nanomedicine       Date:  2011-11-24

8.  p28, a first in class peptide inhibitor of cop1 binding to p53.

Authors:  T Yamada; K Christov; A Shilkaitis; L Bratescu; A Green; S Santini; A R Bizzarri; S Cannistraro; T K D Gupta; C W Beattie
Journal:  Br J Cancer       Date:  2013-06-04       Impact factor: 7.640

9.  Microbial Azurin Immobilized on Nano-Chitosan as Anticancer and Antibacterial Agent Against Gastrointestinal Cancers and Related Bacteria.

Authors:  Nawal E Al-Hazmi; Deyala M Naguib
Journal:  J Gastrointest Cancer       Date:  2021-06-22

10.  The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer cell models.

Authors:  Nuno Bernardes; Ana Sofia Ribeiro; Sofia Abreu; Bruna Mota; Rute G Matos; Cecilia M Arraiano; Raquel Seruca; Joana Paredes; Arsenio M Fialho
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.